Neurology

  • Fibromuscular dysplasia: Advances in understanding and management
    Ellen K. Brinza, MS and Heather L. Gornik, MD
    Cleveland Clinic Journal of Medicine November 2016, 83 (11 suppl 2) S45-S51; DOI: https://doi.org/10.3949/ccjm.83.s2.06
  • An abnormal peripheral blood smear and altered mental status
    Supakanya Wongrakpanich, MD, Moiz Salahuddin, MD and Priyanka Mittar, DO
    Cleveland Clinic Journal of Medicine September 2016, 83 (9) 643-644; DOI: https://doi.org/10.3949/ccjm.83a.15152

    Therapeutic plasma exchange has greatly increased the survival rate in thrombotic thrombocytopenic purpura.

  • Thrombotic thrombocytopenic purpura: The role of ADAMTS13
    Heesun J. Rogers, MD, PhD, Charles Allen, DO and Alan E. Lichtin, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 597-603; DOI: https://doi.org/10.3949/ccjm.83a.15009

    ADAMTS13 testing is useful in diagnosing this disease, guiding therapy, and predicting relapse.

  • Anticoagulation in dental surgery: Is it rude to interrupt?
    Michael J. Wahl, DDS
    Cleveland Clinic Journal of Medicine June 2016, 83 (6) 409-413; DOI: https://doi.org/10.3949/ccjm.83a.15014

    Anticoagulation should not be interrupted for dental surgery.

  • Multiple linear subcutaneous nodules
    Gitesh U. Sawatkar, MD, Dipankar De, MD, Uma Nahar Saikia, MD and Sanjeev Handa, MD, FRCP (EDIN)
    Cleveland Clinic Journal of Medicine June 2016, 83 (6) 414-416; DOI: https://doi.org/10.3949/ccjm.83a.15058

    A 34-year-old woman has an asymptomatic swelling on her foot that has been slowly growing for 15 years.

  • Predicting is tough, especially about the future
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine May 2016, 83 (5) 324; DOI: https://doi.org/10.3949/ccjm.83b.05016

    All risk calculators—not just for anticoagulation—are based on the “average” patient. And no patient is average.

  • How can I predict bleeding in my elderly patient taking anticoagulants?
    Gene R. Quinn, MD, MS and Margaret C. Fang, MD, MPH
    Cleveland Clinic Journal of Medicine May 2016, 83 (5) 345-348; DOI: https://doi.org/10.3949/ccjm.83a.15002

    We have tools, but their predictive value is modest. Clinical judgment is important.

  • Zika—a new continent and new complications?
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine April 2016, 83 (4) 247-248; DOI: https://doi.org/10.3949/ccjm.83b.04016

    Zika reminds us that we live in a medically connected global community.

  • Zika virus: A primer for clinicians
    Michelle S. Flores, MD, Timothy H. Burgess, MD, MPH and Michael Rajnik, MD
    Cleveland Clinic Journal of Medicine April 2016, 83 (4) 261-270; DOI: https://doi.org/10.3949/ccjm.83a.16027

    Zika is worrisome because of associations with microcephaly and Guillain-Barré syndrome. Watch for updates at cdc.gov.

  • Drugs that may harm bone: Mitigating the risk
    Faye N. Hant, DO, MSCR and Marcy B. Bolster, MD
    Cleveland Clinic Journal of Medicine April 2016, 83 (4) 281-288; DOI: https://doi.org/10.3949/ccjm.83a.15066

    The implicated drugs have important therapeutic roles, so their benefits must be weighed against the risks.

Pages